CVE-2023-32662

Name: CVE-2023-32662
Creator: NVD / NIST
Published: 2023-11-14T19:15:26.987+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 6.7/10EPSS 0.23%

Last modified Jun 17, 2026

CVE-2023-32662 is a medium-severity vulnerability rated 6.7/10 on the CVSS scale. Improper authorization in some Intel Battery Life Diagnostic Tool installation software before version 2.2.1 may allow a privilaged user to potentially enable escalation of privilege via local access.. EPSS estimates a 0.23% chance of exploitation in the next 30 days.

Description

Improper authorization in some Intel Battery Life Diagnostic Tool installation software before version 2.2.1 may allow a privilaged user to potentially enable escalation of privilege via local access.

Metrics

CVSS 3.1

6.7/10

CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

EPSS Probability

0.23%

13.4th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Vendor	Product	Versions
Intel	Battery Life Diagnostic Tool	< 2.2.1

References

https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00843.htmlVendor Advisory
https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00843.htmlVendor Advisory

Timeline

Published: Nov 14, 2023
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2023-32662?

How severe is CVE-2023-32662?

CVE-2023-32662 has a CVSS score of 6.7/10 (MEDIUM severity). The EPSS model estimates a 0.23% probability of exploitation in the next 30 days.

How do I fix CVE-2023-32662?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-32662?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST